Innovations: Measles Programmatic Risk Assessments

Slides:



Advertisements
Similar presentations
Polio Communication Indicators Reflections from Polio Communication TAG/Review Process.
Advertisements

Global Measles and Rubella Strategic Plan
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
Measles Outbreaks in Southern Africa in 2010 Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
The state of the art: DHS and MICS
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
Measles and Rubella Elimination in the WHO European Region: Update on Progress & Challenges Global Measles and Rubella Management Meeting March 2011.
Monitoring & Evaluation for Routine Immunization: Data For Action
Measles outbreak investigation & Response Jordan DR MOHAMAD RATIB SUROUR NATIONAL EPI MANAGER INTER-COUNTRY MEETING ON MEASLES AND RUBELLA CONTROL AND.
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Strengthening Routine Infant Immunization in EMR Partners for Measles Advocacy February, 2007 Eastern Mediterranean Regional Office Vaccines Preventable.
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
Supporting Routine AND Supplementary Immunization Activities in STOP.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
What is “Reaching Every District” (RED) in Immunization? A brief overview Information from the global immunization partnership presented by Lora Shimp.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
1 | Global Immunization Meeting: PIA Sitges, June 2015 New tools and strategies for maternal and neonatal tetanus and measles/rubella elimination.
1 Progress Towards Polio Eradication in EMR. 2 Status of global eradication Priority countries (except EMR) : Intensification : Certification,
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
Funding Update: 2013 – 2015 September 10,
David Featherstone EPI / IVB WHO/HQ Measles Partners Meeting September 2008 Washington Global Measles Rubella Laboratory Network: Update.
Measles pre-elimination in the African Region. Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
Recent Epidemiologic Situations of TB in Myanmar -Preliminary Review of Data from routine TB surveillance focusing on Case Finding- 9 May 2014, Nay Pyi.
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
Situation overview and Meeting Objectives The Middle East Polio Outbreak Phase II Review.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
World Health Organization Western Pacific Regional Office Expanded Programme on Immunization Measles Elimination in the Western Pacific Region 2007 Partners.
Using Surveillance Indicators for Vaccine-Preventable Diseases: National Notifiable Diseases Surveillance System Sandra W. Roush, MT, MPH National.
Measles and Measles Outbreaks in China Accelerating Progress towards Measles/Rubella Control and Elimination Goals Meeting Geneva, Switzerland June 19,
Accelerating Progress towards Measles and Rubella Elimination Eastern Mediterranean Region 1 21 June 2016 Geneva, Switzerland.
How can information systems help us?
Global Measles and Rubella: Highlights, Priorities and Critical Issues
World Health Organization
Session 3: Molecular Epidemiology Introduction
Inclusive Education & Access
Targeted supplementary immunization
Strengthening the 2YL Platform & Men A Introduction Plan in Ghana
Global Overview of Measles
Measles SIA Readiness Assessment-Uganda Experience
53 Member States >900 million inhabitants WHO European Region
World Health Organization
World Health Organization
Texas Department of State Health Services Dr
World Health Organization
Recap of the Midterm Review Recommendations
Content Public Health Emergencies Ebola Virus Disease: DRC
23 November, 2018 Update on measles & rubella surveillance in the WHO African Region – progress and challenges Dr Richard Luce WHO/IST-Central 5th African.
Content Public Health Emergencies Ebola Virus Disease: DRC
Stakeholder Consultation
Epidemiological Update on Public Health Emergencies
African Region- priorities to reach the 2020 measles elimination goal.
Experience with the measles outbreak response fund
DRC Challenges with Multiple Surveillance Systems
Data sharing practices in the region
World Health Organization
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
Maintaining Elimination in an Environment of Persistent Importation
Partners for Measles Advocacy—7th Annual Meeting
TRACE INITIATIVE: Data Use
Illustrative Cluster Detection and Response Strategy
National Immunization Conference
Presentation transcript:

Innovations: Measles Programmatic Risk Assessments June 21-23, 2016, Geneva, Switzerland Accelerating Progress towards Measles/Rubella Control and Elimination Goals James L. Goodson Global Immunization Division Centers for Disease Control and Prevention

Measles Risk Assessments Sudan Zimbabwe Senegal Namibia Philippines Shan Dong Province China Uttarakhand State, India Laos Nepal

Measles Risk Assessments Designed to use multiple programmatic indicators to identify areas with programmatic weaknesses. Not a tool for predicting outbreaks but rather for preventing them

Intended Uses Can be used annually to monitor progress Planning and prioritization activities for program Guide efforts for SIA, ORI planning VPD surveillance reviews Immunization Services Delivery and EPI reviews Advocacy and resource mobilization WHO Regional Offices and RVCs are advocating for use of the tool Results from the risk assessment tool are intended to be used for planning and prioritization of program response, and targeted immunization response tailored to level of risk. High-risk districts identified by the tool can be prioritized for interventions to strengthen surveillance, increase routine vaccination coverage, as well as recommend detailed micro-planning and supervision during supplemental immunization activities. Importantly, the risk tool is not meant for predicting outbreaks, but rather for preventing them through strengthening immunization and surveillance programs. Intended use of the results may include the following: Annual updates to monitor progress, Supplemental immunization activity and outbreak response immunization planning, Measles case-based surveillance reviews, Routine immunization EPI reviews, and advocacy and resource mobilization.

Data Inputs Routinely-collected and readily-available data District-level data (3rd administrative level) DPT1 (or Penta1) and MCV1, MCV2 coverage data SIA and ORI coverage data Measles case-based surveillance Population density Shape files for mapping EPI experience and local knowledge of threats in each district Sources of data for the risk assessment are routinely collected and readily available, and available at the 3rd administrative – or district – level, in order to ensure that the end product remains user-friendly. Data inputs include administrative coverage data for measles and other vaccines, SIA or district-wide outbreak response campaign coverage, case-based measles surveillance data, and local knowledge.

Immunization services delivery performance Categories of Risk Indicators Population immunity Threats District-level risk calculated based on data inputs in 4 main categories: Immunization services delivery performance The measles risk tool includes a range of data inputs, in addition to vaccination coverage. These include indicators for population immunity, surveillance quality, program delivery performance, and threat assessment. The overall risk is assessed as a function of indicator scores from these four main categories. The subtotal scores from the four indicator categories are shown here. A total maximum overall score of 100 was used for easier interpretation and to allow for more transparency with direct scoring. Surveillance quality Range of possible scores: 0-100 *Each category has a list of indicators with various cut-off criteria to assign risk points

cut-offs (risk points) 1. Population Immunity Population Immunity (40%) cut-offs (risk points) MCV1 coverage ≥95% (0) 90-94% (2) 85-89% (4) 80-84% (6) <80% (8) MCV2 coverage 90-94% (2) 85-89% (4) 80-84% (6) <80% (8) Percentage of neighboring districts with <80% MCV1 <50% (0) 50-74% (2) ≥75% (4) Measles SIA conducted within the past 3 years Yes, ≥95% coverage (0) Yes, 90-94% coverage (2) Yes, 85-89% coverage (4) Yes, <85% covg / no data (6) No SIA (8) Target age group of measles SIA conducted within the past 3 years Wide age group (0) Narrow age group* (2) *<5 birth cohorts Years since last measles SIA <1 year (0) 2 years (2) >3 years (4) % suspected measles cases with unvaccinated or unknown vax status <20% (0) >20% (6) Immunization Service Delivery Major risk categories and scoring of indicators were developed during a workshop attended by representatives from WHO regional offices and partners as an extension of the Global Measles and Rubella Management Meeting. SIAs Both

2. Surveillance Performance cut-offs (risk points) Non-measles discarded rate (/100,000) ≥2 (0) <2 (4) <1 (8) % with adequate investigation* rate ≥80% (0) <80% (4) % with adequate specimen collection** (within 28 days of rash onset) % with timely availability of laboratory results*** (within 10 days of specimen collection)

3. Immunization Services Delivery Program Performance Program Delivery Performance (16%) cut-offs (risk points) Trends in MCV1 coverage Increasing or same (0) ≤10% decline (2) >10% decline (4) Trends in MCV2 coverage MCV1-MCV2 dropout rate ≤10% (0) >10% (4) DPT1-MCV1 dropout rate

cut-offs (risk points) 4. Threats Threat Assessment (24%) cut-offs (risk points) ≥1 measles case reported in past year among those aged <5 years No (0) Yes (4) ≥1 measles case reported in past year among those aged 5-14 years Yes (3) ≥1 measles case reported in past year among those aged ≥15 years Population Density (per km2) 0-50 (0) 51-100 (1) 101-300 (2) 301-1000 (3) >1000 (4) ≥1 measles case reported in a bordering district in past year Yes (2) Presence of vulnerable population groups (source: local knowledge) No vulnerable groups (0) One risk point for each vulnerable group range 1-8 Evidence of recent measles cases among children <5 / 5-14 / ≥15 years of age Data source: Measles case-based surveillance (latest year). One or more confirmed or measles compatible case reported in a district within the past calendar year among those with various age groups. Include confirmed, epidemiologically-linked, and measles compatible cases. Exclude discarded cases. More risk points are given to those under 5 as they are usually the main group for transmission and have the higher burden of disease. 4. Population density (urban vs rural) Data source: Administrative data from National Statistics Office or local knowledge. Data categorizes each district as urban or rural. Assign risk point for urban districts. 5. Bordering area with measles case in the past 12 months Data source: Measles case-based surveillance (latest year). One or more confirmed or measles compatible case reported in a bordering district within the past calendar year. Include confirmed, epidemiologically-linked, and measles compatible cases. Exclude discarded cases. This indicator is representative of the threat of importation. All land borders should be considered at risk; for island borders, refer to local knowledge whether there is frequent population movement with neighboring district. 6. Presence of vulnerable population groups Data source: Local knowledge. Assign one risk point for each of the following vulnerable population groups present in a district. Presence of chronically unreached due to: Presence of migrant population, internally displaced population, slums, or tribal communities, Resistant to vaccination (i.e., religious, cultural issues, etc.), Security and safety concerns, Frequented by calamities/disasters, Poor access to health services due to terrain/transportation issues, Lack of local political support.

Risk Tool Software Package Excel-based, electronic formatting Easy data entry – automation, import from external data sources, user-friendly User’s guide with more detailed information on indicators and special circumstances

Risk Tool Software Package - Setup Guide

Risk Tool Spreadsheet: Data Entry

Risk Tool Spreadsheet: Indicator Categories and Total Risk Points

Risk Tool Software Package

Risk Tool Software Package

Challenges and Lessons Learned The quality of a risk assessment is only as good as the quality of the data that goes into it Coverage data (MCV1, MCV2, SIAs) Population estimates Case-based surveillance data Requires basic data management skills to follow the instructions for cleaning and preparing the data Map files Districts may have changed over the years used in the risk assessment Sources of funding are needed for risk mitigation activities based on the assessment results

Future Next Steps Complete beta testing of the risk tool software to finalize Make the tool and user’s guide widely available through a link on the WHO website by end 2016 Develop a E-learning training module Identify risk mitigation funding opportunities Consider reporting-up of completed assessments, for regional and global monitoring and use of country-level results (assessing clustering of risks across borders) Accumulate lessons learned and experience, consider development of version 2.0, and integration into a future global data management system to monitor and guide elimination efforts globally

Thank You

Very High Risk Districts Risk Scores PI=Population Immunity (Total=40) SQ=Surveillance Quality (Total=20) Very High Risk Districts PDP=Program Delivery Performance (Total=16) TA=Threat Assessment (Total=24) Risk Points Satu Mare (64) Neamt (71) Arad (76) Bacau (64) Timis (68) Ialomita (68) Caras (63) Constanta (63)

Cut-off Criteria for Risk Categories Fixed cut-off points based on a theoretical distribution Standardization of risk assignments Allows for comparisons across countries and regions as well as within a country over time Risk Categories Total risk points Low risk ≤ 47 Medium risk 48-54 High risk 55-60 Very high risk ≥ 61 Scores from each category are combined to assign an overall risk score for each district. The tool uses fixed cut-off points based on a theoretical distribution to categorize the overall risk scores into low, medium, high, or very high risk. Standardizing the risk assignments based on the theoretical distribution does not force every country to have 25% of each risk category and allows for direct comparisons across countries and regions, and also within a country over time.

Limitations Data quality (what goes in, is what comes out) Reliability of results However, might be useful to show outbreak areas with low risk that need efforts to improve data quality WHO tool is generalized for a variety of settings, uses standardized scoring and cut-off values However, may be useful to use additional country-specific indicators in addition to the fixed set Caution against allowing too much flexibility that might allow manipulation for arriving at desirable results